| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |